Advances in cancer immunotherapy to be spotlighted at Dr. Paul Janssen Award Symposium

NEW YORK, September 4, 2018 – James P. Allison, PhD, the Vivian L. Smith Distinguished Chair in Immunology, Director of the Parker Institute for Cancer Research, and the Executive Director of the Immunotherapy Platform at MD Anderson Cancer Center will be honored at the 2018 Dr. Paul Janssen Award Symposium, for his work on cancer immunotherapies that leverage the immune system to better fight cancer.

At the symposium, presented by the Dr. Paul Janssen Award for Biomedical Research and the New York Academy of Sciences, today’s leading experts will highlight recent advances in immuno-oncology, and discuss innovative strategies for optimizing cancer treatment. They include Elizabeth Mittendorf, MD, PhD, Brigham and Women’s Hospital and Dana-Farber Cancer Institute; Matthew Mulvey, PhD, Janssen Pharmaceutical Companies of Johnson & Johnson; Dana Pe’er, PhD, Memorial Sloan Kettering Cancer Center; Alexander Rudensky, PhD, Memorial Sloan Kettering Cancer Center; and Padmanee Sharma, MD, PhD, The University of Texas MD Anderson Cancer Center.

“I feel very honored to receive an award named for Paul Janssen, perhaps the most prolific inventor in the history of drugs to treat important human diseases,” said Dr. Allison. “I am also very excited to participate in the symposium, where recent advancements and


Article originally posted at

Click here for the full story


Privacy Policy / Terms Of Use

       Powered by MMD